Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
European Heart Journal - Cardiovascular Pharmacotherapy
JournalCitation impact & published research
European Heart Journal - Cardiovascular Pharmacotherapy is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 963 works, 16,096 citations, an h-index of 59 and an APC (USD) of 3,895.
963
Works
16,096
Citations
59
h-index
3,895
APC (USD)
IDs:OpenAlex
What are the most-cited papers on European Heart Journal - Cardiovascular Pharmacotherapy?
ScholarIQmost cited works
Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial
Masanori Asakura, Shin Ito, Takahisa Yamada, Yoshihiko Saito, Kazuo Kimura, Akira Yamashina, Atsushi Hirayama, Youichi Kobayashi, Akihisa Hanatani, Mitsuru Tsujimoto, Satoshi Yasuda, Yukio Abe, Yorihiko Higashino, Yodo Tamaki, Hiroshi Sugino, Hiroyuki Niinuma, Yoshitaka Okuhara, Toshimi Koitabashi, Shin‐ichi Momomura, Kuniya Asai, Akihiro Nomura, Hiroya Kawai, Yasuhiro Satoh, Tsutomu Yoshikawa, Ken–ichi Hirata, Yoshiaki Yokoi, Jun Tanaka, Yoshisato Shibata, Yasuhiro Maejima, Shunsuke Tamaki, Hiroyuki Kawata, Noriaki Iwahashi, Masatake Kobayashi, Yoshiharu Higuchi, Akiko Kada, Haruko Yamamoto, Masafumi Kitakaze
European Heart Journal - Cardiovascular Pharmacotherapy. 202042 Citations
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
Gerasimos Filippatos, Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky, Peter Rossing, Luís M. Ruilope, Bertram Pitt, Pantelis Sarafidis, John R. Teerlink, Chris J. Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George L. Bakris, Rajiv Agarwal
European Heart Journal - Cardiovascular Pharmacotherapy. 202341 CitationsOPEN ACCESS
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
Craig I Coleman, William L. Baker, Anna‐Katharina Meinecke, Daniel Eriksson, Brandon Martinez, Thomas J. Bunz, Mark J. Alberts
European Heart Journal - Cardiovascular Pharmacotherapy. 201930 CitationsOPEN ACCESS
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
Gerasimos Filippatos, Stefan D. Anker, Bertram Pitt, Darren K. McGuire, Peter Rossing, Luís M. Ruilope, Javed Butler, Ewa A. Jankowska, Erin D. Michos, Dimitrios Farmakis, Alfredo E. Farjat, Peter Kolkhof, Andrea Scalise, Amer Joseph, George L. Bakris, Rajiv Agarwal
European Heart Journal - Cardiovascular Pharmacotherapy. 202229 CitationsOPEN ACCESS
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
Mingming Yang, Alasdair D Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Jean L. Rouleau, Karl Swedberg, Muthiah Vaduganathan, Dirk J van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Adel R. Rizkala, Eldrin F. Lewis, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
European Heart Journal - Cardiovascular Pharmacotherapy. 20251 CitationsOPEN ACCESS
Related on ScholarIQ
Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial
Paper
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
Paper
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
Paper
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
Paper
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
Paper
Atrial Fibrillation Management and Outcomes
Topic